The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: Role of cytochrome P4501B1

Bhagavatula Moorthy, Kimberly P. Miller, Weiwu Jiang, Kenneth Ramos

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: 3-Methylcholanthrene (MC), a polycylic aromatic hydrocarbon, induces atherogenesis in mice fed an atherogenic diet. In this study, we tested the hypothesis that MC would induce DNA adducts in mouse aortic smooth muscle cells (SMCs) and that cytochrome P4501B1 (CYP1B1) plays an important role in the activation of MC to genotoxic intermediates. Methods: Cultured SMCs were treated with MC or the vehicle dimethyl sulfoxide (DMSO), and DNA was isolated after 24 h. In some experiments, the cells were pre-treated with the CYP1B1 inhibitor 1-ethynylpyrene (EP) prior to exposure to MC. DNA adducts were determined by the 32P-postlabeling assay. Aryl hydrocarbon hydroxylase assay was measured by fluorimetry. Results: MC induced formation of 12 DNA adducts that were not observed in DMSO-treated cells. DNA adduct formation was dose-dependent, with maximum response observed at 3 μM. Pre-treatment of cells with EP dramatically suppressed DNA adduct formation by MC. MC treatment caused induction of CYP1B1, but not CYP1A1. Conclusion: The induction of high levels of multiple DNA adducts in SMCs by MC suggests that SMCs have a functional enzymatic machinery capable of metabolically activating MC to genotoxic metabolites. The significant inhibition by EP of MC-induced DNA adduct formation indicated that CYP1B1 was the primary CYP enzyme responsible for formation of genotoxic metabolites that may play a role in the induction of atherosclerosis by MC.

Original languageEnglish (US)
Pages (from-to)1002-1009
Number of pages8
JournalCardiovascular Research
Volume53
Issue number4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Methylcholanthrene
DNA Adducts
Smooth Muscle Myocytes
Dimethyl Sulfoxide
Cytochrome P-450 CYP1B1
Atherosclerosis
Atherogenic Diet
Aryl Hydrocarbon Hydroxylases
Aromatic Hydrocarbons
Fluorometry
Cytochrome P-450 CYP1A1

Keywords

  • Atherosclerosis
  • Cell culture/isolation
  • Free radicals
  • Signal transduction
  • Smooth muscle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells : Role of cytochrome P4501B1. / Moorthy, Bhagavatula; Miller, Kimberly P.; Jiang, Weiwu; Ramos, Kenneth.

In: Cardiovascular Research, Vol. 53, No. 4, 2002, p. 1002-1009.

Research output: Contribution to journalArticle

@article{58986af308094d5e906639af36c41dba,
title = "The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: Role of cytochrome P4501B1",
abstract = "Objective: 3-Methylcholanthrene (MC), a polycylic aromatic hydrocarbon, induces atherogenesis in mice fed an atherogenic diet. In this study, we tested the hypothesis that MC would induce DNA adducts in mouse aortic smooth muscle cells (SMCs) and that cytochrome P4501B1 (CYP1B1) plays an important role in the activation of MC to genotoxic intermediates. Methods: Cultured SMCs were treated with MC or the vehicle dimethyl sulfoxide (DMSO), and DNA was isolated after 24 h. In some experiments, the cells were pre-treated with the CYP1B1 inhibitor 1-ethynylpyrene (EP) prior to exposure to MC. DNA adducts were determined by the 32P-postlabeling assay. Aryl hydrocarbon hydroxylase assay was measured by fluorimetry. Results: MC induced formation of 12 DNA adducts that were not observed in DMSO-treated cells. DNA adduct formation was dose-dependent, with maximum response observed at 3 μM. Pre-treatment of cells with EP dramatically suppressed DNA adduct formation by MC. MC treatment caused induction of CYP1B1, but not CYP1A1. Conclusion: The induction of high levels of multiple DNA adducts in SMCs by MC suggests that SMCs have a functional enzymatic machinery capable of metabolically activating MC to genotoxic metabolites. The significant inhibition by EP of MC-induced DNA adduct formation indicated that CYP1B1 was the primary CYP enzyme responsible for formation of genotoxic metabolites that may play a role in the induction of atherosclerosis by MC.",
keywords = "Atherosclerosis, Cell culture/isolation, Free radicals, Signal transduction, Smooth muscle",
author = "Bhagavatula Moorthy and Miller, {Kimberly P.} and Weiwu Jiang and Kenneth Ramos",
year = "2002",
doi = "10.1016/S0008-6363(01)00536-3",
language = "English (US)",
volume = "53",
pages = "1002--1009",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells

T2 - Role of cytochrome P4501B1

AU - Moorthy, Bhagavatula

AU - Miller, Kimberly P.

AU - Jiang, Weiwu

AU - Ramos, Kenneth

PY - 2002

Y1 - 2002

N2 - Objective: 3-Methylcholanthrene (MC), a polycylic aromatic hydrocarbon, induces atherogenesis in mice fed an atherogenic diet. In this study, we tested the hypothesis that MC would induce DNA adducts in mouse aortic smooth muscle cells (SMCs) and that cytochrome P4501B1 (CYP1B1) plays an important role in the activation of MC to genotoxic intermediates. Methods: Cultured SMCs were treated with MC or the vehicle dimethyl sulfoxide (DMSO), and DNA was isolated after 24 h. In some experiments, the cells were pre-treated with the CYP1B1 inhibitor 1-ethynylpyrene (EP) prior to exposure to MC. DNA adducts were determined by the 32P-postlabeling assay. Aryl hydrocarbon hydroxylase assay was measured by fluorimetry. Results: MC induced formation of 12 DNA adducts that were not observed in DMSO-treated cells. DNA adduct formation was dose-dependent, with maximum response observed at 3 μM. Pre-treatment of cells with EP dramatically suppressed DNA adduct formation by MC. MC treatment caused induction of CYP1B1, but not CYP1A1. Conclusion: The induction of high levels of multiple DNA adducts in SMCs by MC suggests that SMCs have a functional enzymatic machinery capable of metabolically activating MC to genotoxic metabolites. The significant inhibition by EP of MC-induced DNA adduct formation indicated that CYP1B1 was the primary CYP enzyme responsible for formation of genotoxic metabolites that may play a role in the induction of atherosclerosis by MC.

AB - Objective: 3-Methylcholanthrene (MC), a polycylic aromatic hydrocarbon, induces atherogenesis in mice fed an atherogenic diet. In this study, we tested the hypothesis that MC would induce DNA adducts in mouse aortic smooth muscle cells (SMCs) and that cytochrome P4501B1 (CYP1B1) plays an important role in the activation of MC to genotoxic intermediates. Methods: Cultured SMCs were treated with MC or the vehicle dimethyl sulfoxide (DMSO), and DNA was isolated after 24 h. In some experiments, the cells were pre-treated with the CYP1B1 inhibitor 1-ethynylpyrene (EP) prior to exposure to MC. DNA adducts were determined by the 32P-postlabeling assay. Aryl hydrocarbon hydroxylase assay was measured by fluorimetry. Results: MC induced formation of 12 DNA adducts that were not observed in DMSO-treated cells. DNA adduct formation was dose-dependent, with maximum response observed at 3 μM. Pre-treatment of cells with EP dramatically suppressed DNA adduct formation by MC. MC treatment caused induction of CYP1B1, but not CYP1A1. Conclusion: The induction of high levels of multiple DNA adducts in SMCs by MC suggests that SMCs have a functional enzymatic machinery capable of metabolically activating MC to genotoxic metabolites. The significant inhibition by EP of MC-induced DNA adduct formation indicated that CYP1B1 was the primary CYP enzyme responsible for formation of genotoxic metabolites that may play a role in the induction of atherosclerosis by MC.

KW - Atherosclerosis

KW - Cell culture/isolation

KW - Free radicals

KW - Signal transduction

KW - Smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0036196883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036196883&partnerID=8YFLogxK

U2 - 10.1016/S0008-6363(01)00536-3

DO - 10.1016/S0008-6363(01)00536-3

M3 - Article

C2 - 11922910

AN - SCOPUS:0036196883

VL - 53

SP - 1002

EP - 1009

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 4

ER -